ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2014

Nivolumab: promising survival signal coupled with limited toxicity raises expectations.

Geraldine O'Sullivan Coyne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.